Inhibitory effect of activated protein C on activation of prothrombin by platelet-bound factor Xa.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  European Journal of Biochemistry

• Publication date

  2005-03-03

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1111/J.1432-1033.1980.TB06033.XPMID 6893181
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vitamin K Metabolism and Vitamin K Dependent Proteins

  1980cited by this paper
• The activation of prothrombin by platelet-bound factor Xa.

  1980cited by this paper
• Human plasma protein C: isolation, characterization, and mechanism of activation by alpha-thrombin.

  1979cited by this paper
• Human Plasma Protein C: ISOLATION, CHARACTERIZATION, AND MECHANISM OF ACTIVATION BY α-THROMBIN

  1979cited by this paper
• Bovine protein C: amino acid sequence of the light chain.

  1978cited by this paper
• Binding of bovine coagulation factor Xa to platelets.

  1978cited by this paper
• Properties of the factor Xa binding site on human platelets.

  1978cited by this paper
• Patients with congenital factor V deficiency have decreased factor Xa binding sites on their platelets.

  1978cited by this paper
• Factor V activity of platelets: evidence for an activated factor V molecule and for a platelet activator

  1977cited by this paper
• Factor V activity of platelets: evidence for an activated factor V molecule and for a platelet activator.

  1977cited by this paper
• Interaction of coagulation factor Xa with human platelets.

  1977cited by this paper
• Prothrombin structure, activation, and biosynthesis.

  1977cited by this paper
• Anticoagulant properties of bovine plasma protein C following activation by thrombin.

  1977cited by this paper
• Proteolytic activation of protein C from bovine plasma.

  1976cited by this paper
• A new vitamin K-dependent protein. Purification from bovine plasma and preliminary characterization.

  1976cited by this paper
• Relationship of "new" vitamin K-dependent Protein C and "old" autoprothrombin II-a.

  1976cited by this paper
• The activation of bovine coagulation factor X.

  1976cited by this paper
• Factor X activating enzyme from Russell's viper venom: isolation and characterization.

  1976cited by this paper
• The Localization of Factor V within Normal Human Platelets and the Demonstration of a Platelet‐Factor V Antigen in Congenital Factor V Deficiency

  1975cited by this paper
• Preparation and partial characterization of two forms of bovine thrombin.

  1975cited by this paper
• Polyethylene glycol 6,000 enhancement of the clotting of fibrinogen solutions in visual and mechanical assays.

  1974cited by this paper
• The binding of thrombin to the surface of human platelets.

  1974cited by this paper
• Enzymatic iodination of polypeptides with 125I to high specific activity.

  1971cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• THROMBOKINASE AS PRIME ACTIVATOR OF PROTHROMBIN: HISTORICAL PERSPECTIVES AND PRESENT STATUS.

  1964cited by this paper
• The Stuart-Prower Factor Assay and its Clinical Significance

  1958cited by this paper

• Unexplained bleeding: another player to look out for!

  2014cites this paper
• Interactions Between Platelets and the Coagulation System

  2013cites this paper
• Role of fibrin structure in thrombosis and vascular disease.

  2011cites this paper
• The tale of protein S and C4b-binding protein, a story of affection

  2007cites this paper
• CHAPTER 19 – Interactions Between Platelets and the Coagulation System

  2007cites this paper
• Role of plasma, platelets, and endothelial cells in tumor metastasis

  2004cites this paper
• Platelet Coagulation-Protein Interactions

  2004cites this paper
• Platelet coagulation-protein interactions.

  2004cites this paper
• Activated Protein C Prevents Development of Phosphatidylserine-Induced Intrauterine Growth Restriction in Mice

  2001cites this paper
• Platelets, vessel wall, and the coagulation system

  1997cites this paper
• Separation of recombinant human protein C from transgenic animal milk using immobilized metal affinity chromatography.

  1997cites this paper
• Protein C activation on endothelial cells by prothrombin activation products generated in situ: meizothrombin is a better protein C activator than alpha-thrombin.

  1996cites this paper
• Coagulation for blood bankers.

  1996cites this paper
• Aprotinin in therapeutic doses inhibits chromogenic peptide substrate assays for protein C.

  1994cites this paper
• Normalization of markers of coagulation activation with a purified protein C concentrate in adults with homozygous protein C deficiency.

  1993cites this paper
• Normalization of markers of coagulation activation with a purified protein C concentrate in adults with homozygous protein C deficiency

  1993cites this paper
• Glycosaminoglycans and the regulation of blood coagulation.

  1993cites this paper
• Inhibitory effect of activated protein C on platelet aggregation induced by the prothrombin-converting reaction.

  1992cites this paper
• The mammalian blood platelet: its role in haemostasis, inflammation and tissue repair.

  1992cites this paper
• Binding of anticoagulant vitamin K-dependent protein S to platelet-derived microparticles.

  1992cites this paper
• Synthesis of protein C in human umbilical vein endothelial cells.

  1991cites this paper
• The role of the endothelium in in vivo anticoagulation.

  1991cites this paper
• Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles.

  1991cites this paper
• The interaction between complement component C4b-binding protein and the vitamin K-dependent protein S forms a link between blood coagulation and the complement system.

  1991cites this paper
• Biological relevance of the protein C system and laboratory diagnosis of protein C and protein S deficiencies.

  1990cites this paper
• Protein C Inhibitor and Other Components of the Protein C Pathway in Patients with Acute Deep Vein Thrombosis during Heparin Treatment

  1990cites this paper
• Impact of Biotechnology on the Diagnostics of Thrombotic Disorders

  1989cites this paper
• Protein C and protein S.

  1989cites this paper
• Protein C and Protein S

  1989cites this paper
• 10 Protein C and protein S

  1989cites this paper
• The role of protein C in congenital and acquired thrombotic disorders.

  1988cites this paper
• Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.

  1988cites this paper
• Inactivation of human plasma kallikrein and factor XIa by protein C inhibitor.

  1988cites this paper
• Genetic coagulation defects.

  1987cites this paper
• Biochemical and functional properties of protein C and protein S.

  1987cites this paper
• Thrombosis in inherited deficiencies of antithrombin, protein C, and protein S.

  1987cites this paper
• Characterization of a cDNA for human protein C inhibitor. A new member of the plasma serine protease inhibitor superfamily.

  1987cites this paper
• The biochemistry and pathophysiology of the prethrombotic state.

  1987cites this paper
• Three-dimensional structure of protein C inhibitor predicted from structure of alpha 1-antitrypsin with computer graphics.

  1987cites this paper
• [Protein C, protein S].

  1987cites this paper
• Clinical relevance of protein C

  1986cites this paper
• 7 – A Model for Assembly of Coagulation Factor Complexes on Cell Surfaces: Prothrombin Activation on Platelets

  1986cites this paper
• Quantitative Immunoblotting of Plasma and Platelet Protein S

  1986cites this paper
• Chapter 9B Inhibitors: protein C

  1986cites this paper
• Role of accessory components in the activation of vitamin K-dependent coagulation factors.

  1986cites this paper
• The natural anticoagulants.

  1986cites this paper
• Platelet-mediated coagulant protein interactions in hemostasis.

  1985cites this paper
• [General mechanisms of coagulation and their physiological inhibition. II. The regulation of coagulation by physiological inhibitors].

  1985cites this paper
• Protein S is required for bovine platelets to support activated protein C binding and activity.

  1985cites this paper
• Characterization of monoclonal antibodies against human protein C specific for the calcium ion‐induced conformation or for the activation peptide region

  1985cites this paper
• Enzyme immunoassay of human protein C by using monoclonal antibodies.

  1985cites this paper
• Pathophysiologic characteristics of venous thrombosis.

  1985cites this paper
• Prevention of Thrombosis in Arteries: Novel Approaches

  1985cites this paper
• Membrane-bound enzyme complexes in blood coagulation.

  1984cites this paper
• The roles of protein C and thrombomodulin in the regulation of blood coagulation.

  1984cites this paper
• Loss of prothrombin and of factor Xa-factor Va interactions upon inactivation of factor Va by activated protein C.

  1984cites this paper
• Activated Protein C Inhibitor

  1984cites this paper
• Characterization of a cDNA coding for human protein C.

  1984cites this paper
• Mechanism of inhibition of activated protein C by protein C inhibitor.

  1984cites this paper
• Protein S is essential for the activated protein C-catalyzed inactivation of platelet-associated factor Va.

  1984cites this paper
• Diagnosis and treatment of recurrent venous thromboembolism.

  1984cites this paper
• Structure and Function of Protein C

  1984cites this paper
• Natural anticoagulant mechanisms.

  1984cites this paper
• Factor X.

  1984cites this paper
• Response of protein C and protein C inhibitor to warfarin therapy in patient with combined deficiency of Factors V and VIII.

  1984cites this paper
• Interactions of thrombin, antithrombin III, and Protein C with endothelium

  1984cites this paper
• Protein C inhibitor. Purification from human plasma and characterization.

  1983cites this paper
• The Coagulation System

  1983cites this paper
• Human protein C and thromboembolic disease.

  1983cites this paper
• The lung as an endocrine organ.

  1983cites this paper
• Protein C Deficiency in Two Austrian Families

  1983cites this paper
• Protein-C: biochemistry, physiology, and clinical implications.

  1983cites this paper
• Inherited protein C deficiency and coumarin-responsive chronic relapsing purpura fulminans in a newborn infant.

  1983cites this paper
• Recent apects on platelets

  1983cites this paper
• Inactivation of human coagulation factor V by activated protein C.

  1983cites this paper
• Activation of Protein C by a Complex between Thrombin and Endothelial Cell Surface Protein

  1982cites this paper
• Generation of prothrombin-converting activity and the exposure of phosphatidylserine at the outer surface of platelets.

  1982cites this paper
• Protein C, an antithrombotic protein, is reduced in hospitalized patients with intravascular coagulation.

  1982cites this paper
• Proteolytic aspects of blood coagulation. Fibrinolysis·kinin-forming systems A review

  1982cites this paper
• The control of hemostasis. Role of endothelium in the regulation of inhibitory and catabolic pathways.

  1982cites this paper
• Studies of the capacity of factor Xa to protect factor Va from inactivation by activated protein C.

  1982cites this paper
• Protein C, a Regulator of Prothrombin Activation

  1982cites this paper
• Amino acid sequence of the light chain of bovine protein C.

  1982cites this paper
• Protein C Deficiency in a Dutch Family with Thrombotic Disease

  1982cites this paper
• [26] Protein C

  1981cites this paper
• Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C.

  1981cites this paper
• Deficiency of protein C in congenital thrombotic disease.

  1981cites this paper
• Deficiency of protein C inhibitor in combined factor V/VIII deficiency disease.

  1980cites this paper